Both iodolipids exert apoptotic effects [27], and our group has demonstrated that 6-IL is present in mammary cancer cells after I2 supplement and is a functional ligand of peroxisome proliferator-activated receptor (PPAR) type gamma (PPARγ) [28-30]. This evidence concerns the gene PPARG and breast cancer.